Legislation roundup: Credit cards, pharma R&D and NEEQ listings

June 08, 2016 | BY

Katherine Jo &clp articles

China is slowly opening up the foreign credit card market, certain R&D reps have been permitted to market drugs and transparency of the New Third Board has been increased

Banking

 

People's Bank of China, Measures for the Administration of Bank Card Settlement Institutions

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]